Compile Data Set for Download or QSAR
maximum 50k data
Found 156 with Last Name = 'fliri' and Initial = 'h'
TargetPeptidyl-prolyl cis-trans isomerase A(Homo sapiens (Human))
Selcia

Curated by ChEMBL
LigandPNGBDBM50230294(CHEMBL4071740)
Affinity DataKi:  4nMAssay Description:Inhibition of full length recombinant human N-terminal His8-tagged Cyclophilin A (1 to 169 residues) expressed in Escherichia coli BL21(DE3) using Su...More data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase A(Homo sapiens (Human))
Selcia

Curated by ChEMBL
LigandPNGBDBM50230211(CHEMBL4063126)
Affinity DataKi:  4.30nMAssay Description:Inhibition of full length recombinant human N-terminal His8-tagged Cyclophilin A (1 to 169 residues) expressed in Escherichia coli BL21(DE3) using Su...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeptidyl-prolyl cis-trans isomerase A(Homo sapiens (Human))
Selcia

Curated by ChEMBL
LigandPNGBDBM50022815((3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33...)
Affinity DataKi:  6.70nMAssay Description:Inhibition of full length recombinant human N-terminal His8-tagged Cyclophilin A (1 to 169 residues) expressed in Escherichia coli BL21(DE3) using Su...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeptidyl-prolyl cis-trans isomerase A(Homo sapiens (Human))
Selcia

Curated by ChEMBL
LigandPNGBDBM50230212(CHEMBL4084776)
Affinity DataKi:  7nMAssay Description:Inhibition of full length recombinant human N-terminal His8-tagged Cyclophilin A (1 to 169 residues) expressed in Escherichia coli BL21(DE3) using Su...More data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase A(Homo sapiens (Human))
Selcia

Curated by ChEMBL
LigandPNGBDBM50230213(CHEMBL4092526)
Affinity DataKi:  14nMAssay Description:Inhibition of full length recombinant human N-terminal His8-tagged Cyclophilin A (1 to 169 residues) expressed in Escherichia coli BL21(DE3) using Su...More data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase A(Homo sapiens (Human))
Selcia

Curated by ChEMBL
LigandPNGBDBM50230210(CHEMBL4090107)
Affinity DataKi:  16nMAssay Description:Inhibition of full length recombinant human N-terminal His8-tagged Cyclophilin A (1 to 169 residues) expressed in Escherichia coli BL21(DE3) using Su...More data for this Ligand-Target Pair
TargetPeptidyl-prolyl cis-trans isomerase A(Homo sapiens (Human))
Selcia

Curated by ChEMBL
LigandPNGBDBM50230209(CHEMBL4100272)
Affinity DataKi:  65nMAssay Description:Inhibition of full length recombinant human N-terminal His8-tagged Cyclophilin A (1 to 169 residues) expressed in Escherichia coli BL21(DE3) using Su...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeptidyl-prolyl cis-trans isomerase A(Homo sapiens (Human))
Selcia

Curated by ChEMBL
LigandPNGBDBM50230293(CHEMBL4082253)
Affinity DataKi:  795nMAssay Description:Inhibition of full length recombinant human N-terminal His8-tagged Cyclophilin A (1 to 169 residues) expressed in Escherichia coli BL21(DE3) using Su...More data for this Ligand-Target Pair
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163042(US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...)
Affinity DataIC50:  4.80nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163050(US9062004, 13)
Affinity DataIC50:  4.80nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163042(US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...)
Affinity DataIC50:  5.40nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163042(US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...)
Affinity DataIC50:  5.40nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163069(US9062004, 36 | US9670216, 36 1-(2-Morpholin-4-yle...)
Affinity DataIC50:  8.5nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163069(US9062004, 36 | US9670216, 36 1-(2-Morpholin-4-yle...)
Affinity DataIC50:  8.5nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163067(US9062004, 34 | US9670216, 34 1-Propyl-5-(3,3,5,5-...)
Affinity DataIC50:  17nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163041(US9062004, 4 | US9670216, 4 4-Chloro-5-dimethylami...)
Affinity DataIC50:  17nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163041(US9062004, 4 | US9670216, 4 4-Chloro-5-dimethylami...)
Affinity DataIC50:  17nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163067(US9062004, 34 | US9670216, 34 1-Propyl-5-(3,3,5,5-...)
Affinity DataIC50:  17nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163065(US9062004, 31 | US9670216, 32 4-Chloro-5-(2-diethy...)
Affinity DataIC50:  20nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163065(US9062004, 31 | US9670216, 32 4-Chloro-5-(2-diethy...)
Affinity DataIC50:  20nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163051(US9062004, 15 | US9670216, 16 4-Chloro-2-(3,5-dime...)
Affinity DataIC50:  22nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163051(US9062004, 15 | US9670216, 16 4-Chloro-2-(3,5-dime...)
Affinity DataIC50:  22.4nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM50005908(CHEMBL3234707 | US9062004, 14 | US9670216, 14 4-Br...)
Affinity DataIC50:  42nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM50005908(CHEMBL3234707 | US9062004, 14 | US9670216, 14 4-Br...)
Affinity DataIC50:  42nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163045(US9062004, 8 | US9670216, 8 5-Propylamino-2-(3,3,5...)
Affinity DataIC50:  68nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163045(US9062004, 8 | US9670216, 8 5-Propylamino-2-(3,3,5...)
Affinity DataIC50:  68nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163048(US9062004, 11 | US9670216, 11 4-Chloro-5-(2-morpho...)
Affinity DataIC50:  83nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163048(US9062004, 11 | US9670216, 11 4-Chloro-5-(2-morpho...)
Affinity DataIC50:  83nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163071(US9062004, 38 | US9670216, 38 1-(2-Dimethylaminoet...)
Affinity DataIC50:  105nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163071(US9062004, 38 | US9670216, 38 1-(2-Dimethylaminoet...)
Affinity DataIC50:  105nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163050(US9062004, 13)
Affinity DataIC50:  174nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163042(US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...)
Affinity DataIC50:  174nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163049(US9062004, 12 | US9670216, 12 4-Chloro-5-(2-dimeth...)
Affinity DataIC50:  204nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163049(US9062004, 12 | US9670216, 12 4-Chloro-5-(2-dimeth...)
Affinity DataIC50:  204nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163069(US9062004, 36 | US9670216, 36 1-(2-Morpholin-4-yle...)
Affinity DataIC50:  219nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163069(US9062004, 36 | US9670216, 36 1-(2-Morpholin-4-yle...)
Affinity DataIC50:  219nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163068(US9062004, 35 | US9670216, 35 2-Propyl-5-(3,3,5,5-...)
Affinity DataIC50:  240nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163068(US9062004, 35 | US9670216, 35 2-Propyl-5-(3,3,5,5-...)
Affinity DataIC50:  240nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163067(US9062004, 34 | US9670216, 34 1-Propyl-5-(3,3,5,5-...)
Affinity DataIC50:  257nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163067(US9062004, 34 | US9670216, 34 1-Propyl-5-(3,3,5,5-...)
Affinity DataIC50:  257nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163040(US9062004, 3 | US9670216, 3 4-Chloro-5-methylamino...)
Affinity DataIC50:  355nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163040(US9062004, 3 | US9670216, 3 4-Chloro-5-methylamino...)
Affinity DataIC50:  355nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163044(US9062004, 7 | US9670216, 7 5-Dimethylamino-2-(3,3...)
Affinity DataIC50:  380nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163044(US9062004, 7 | US9670216, 7 5-Dimethylamino-2-(3,3...)
Affinity DataIC50:  380nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163039(US9062004, 2 | US9670216, 2 4,5-Dichloro-2-(3,3,5,...)
Affinity DataIC50:  389nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163039(US9062004, 2 | US9670216, 2 4,5-Dichloro-2-(3,3,5,...)
Affinity DataIC50:  389nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163042(US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...)
Affinity DataIC50:  1.02E+3nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163041(US9062004, 4 | US9670216, 4 4-Chloro-5-dimethylami...)
Affinity DataIC50:  1.02E+3nMT: 2°CAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 pmol/mg protein, receptor conce...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163041(US9062004, 4 | US9670216, 4 4-Chloro-5-dimethylami...)
Affinity DataIC50:  1.02E+3nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 1(Homo sapiens (Human))
Allergan

US Patent
LigandPNGBDBM163042(US9062004, 5 | US9670216, 13 4-Bromo-5-propylamino...)
Affinity DataIC50:  1.02E+3nMAssay Description:Plasma membranes prepared from HEK 293 EBNA cells transfected with human CB1 or CB2 cannabinoid receptors (3.7 or 3.3 .mu.mol/mg protein, receptor co...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 156 total ) | Next | Last >>
Jump to: